1
|
Duflos C, Labarre JP, Ologeanu R, Robin M, Cayla G, Galinier M, Georger F, Petroni T, Alarcon C, Aguilhon S, Delonca C, Battistella P, Agullo A, Leclercq F, Pasquie JL, Papinaud L, Mercier G, Ricci JE, Roubille F. PRADOC: a trial on the efficiency of a transition care management plan for hospitalized patients with heart failure in France. ESC Heart Fail 2020; 8:1649-1655. [PMID: 33369195 PMCID: PMC8006694 DOI: 10.1002/ehf2.13086] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.3] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/08/2020] [Revised: 08/30/2020] [Accepted: 10/22/2020] [Indexed: 12/22/2022] Open
Abstract
Aims Transition care programmes are designed to improve coordination of care between hospital and home. For heart failure patients, meta‐analyses show a high efficacy but with moderate evidence level. Moreover, difficulties for implementation of such programmes limit their extrapolation. Methods and results We designed a mixed‐method study to assess the implementation of the PRADO‐IC, a nationwide transition programme that aims to be offered to every patient with heart failure in France. This programme consists essentially in an administrative assistance to schedule follow‐up visits and in a nurse follow‐up during 2 to 6 months and aims to reduce the annual heart failure readmission rate by 30%. This study assessed three quantitative aims: the cost to avoid a readmission for heart failure within 1 year (primary aim, intended sample size 404 patients), clinical care pathways, and system economic outcomes; and two qualitative aims: perceived problems and benefits of the PRADO‐IC. All analyses will be gathered at the end of study for a joint interpretation. Strengths of this study design are the randomized controlled design, the population included in six centres with low motivation bias, the primary efficiency analysis, the secondary efficacy analyses on care pathway and clinical outcomes, and the joint qualitative analysis. Limits are the heterogeneity of centres and of intervention in a control group and parallel development of other new therapeutic interventions in this field. Conclusions The results of this study may help decision‐makers to support an administratively managed transition programme.
Collapse
Affiliation(s)
- Claire Duflos
- Clinical Research and Epidemiology Unit, CHU Montpellier, Univ Montpellier, Montpellier, France.,CEPEL, Univ Montpellier, CNRS, Montpellier, France
| | | | - Roxana Ologeanu
- Montpellier Research Management, Univ Montpellier, Montpellier, France
| | - Marie Robin
- Department of Cardiology, Montpellier University Hospital, Montpellier Cedex 5, 34295, France
| | - Guillaume Cayla
- Department of Cardiology, Nimes University Hospital, Montpellier University, Nimes, France
| | - Michel Galinier
- Fédération des Services de Cardiologie, CHU Toulouse-Rangueil, Toulouse, France
| | | | - Thibaut Petroni
- Cardiology, Clinique du Pont de Chaume ELSAN, Montauban, France
| | - Clément Alarcon
- Department of Cardiology, Alès-Cévennes Hospital, Alès cedex, France
| | - Sylvain Aguilhon
- Department of Cardiology, Montpellier University Hospital, Montpellier Cedex 5, 34295, France
| | - Christine Delonca
- Department of Cardiology, Montpellier University Hospital, Montpellier Cedex 5, 34295, France
| | - Pascal Battistella
- Department of Cardiology, Montpellier University Hospital, Montpellier Cedex 5, 34295, France
| | - Audrey Agullo
- Department of Cardiology, Montpellier University Hospital, Montpellier Cedex 5, 34295, France
| | - Florence Leclercq
- Department of Cardiology, Montpellier University Hospital, Montpellier Cedex 5, 34295, France
| | - Jean-Luc Pasquie
- Department of Cardiology, Montpellier University Hospital, Montpellier Cedex 5, 34295, France.,PhyMedExp, Université de Montpellier, INSERM, CNRS, Montpellier, France
| | - Laurence Papinaud
- Direction Régional du Service Médical Languedoc-Roussillon, CNAM, Paris, France
| | - Grégoire Mercier
- CEPEL, Univ Montpellier, CNRS, Montpellier, France.,Public Health Department, Montpellier University Hospital, Montpellier Cedex 5, France
| | - Jean-Etienne Ricci
- Department of Cardiology, Nimes University Hospital, Montpellier University, Nimes, France
| | - François Roubille
- Department of Cardiology, Montpellier University Hospital, Montpellier Cedex 5, 34295, France.,PhyMedExp, Université de Montpellier, INSERM, CNRS, Montpellier, France
| |
Collapse
|